EndoNurse Magazine

Inflammatory Bowel Disease (IBD)

Intestinal Bacteria Promote -- and Prevent! -- Inflammatory Bowel Disease

Bacteria already in the gut eliminates symptoms of inflammatory bowel disease (IBD) in an animal model. ...More
May 29, 2008
Posted in News, Disorders
Cimzia® Approved for Moderate to Severe Crohn's Disease

BRUSSELS, Belgium -- UCB announced that the U.S. Food and Drug Administration (FDA) has approved Cimzia® (certolizumab pegol), the first and only PEGylated anti- TNFa (tumor necrosis factor alpha) antibody indicated for reducing signs and symptoms of Crohn's disease ...More
April 23, 2008
Posted in News, Disorders
Omega-3 Free Fatty Acids Don't Prevent Relapse of Crohn's Disease

CHICAGO – Patients with Crohn's disease who took omega-3 free fatty acids supplements did not have a significantly different rate of relapse compared to patients who took placebo, according to a study in the April 9 issue of JAMA.Effective therapy to maintain ...More
April 8, 2008
Posted in News, Disorders
Mayo Clinic Identifies Infection Risks for Patients with Inflammatory Bowel Disease

ROCHESTER, Minn. -- A new Mayo Clinic study finds that patients who are 50 or older and take multiple immunosuppressive medications for inflammatory bowel disease have a higher risk for developing infections. The study is published in this month's issue of ...More
April 2, 2008
Posted in News, Disorders
Pharma Focus— Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) includes both Crohn’s disease and ulcerative colitis. Approximately one million Americans have IBD, evenly divided between Crohn’s disease and ulcerative colitis, and affecting both genders equally. Ulcerative Colitis According to the ...More
February 19, 2008
Posted in Articles, Disorders, Procedures
Pregnancy Outcomes Differ for Women With Crohn’s and Colitis

NEW YORK -- A recent study supported by the Crohn’s & Colitis Foundation of America, published in the October 2007 issue of Gastroenterology, found that pregnancy outcomes for women with Crohn’s disease and ulcerative colitis differ from those without these chronic ...More
February 5, 2008
Posted in News, Disorders
CCFA Raises $1 Million to Find Cures

MIAMI – On Sunday, Jan. 27, a total of 216 people from 23 states planned to cross the finish line at the ING Miami Half Marathon, knowing that they’d helped the Crohn’s & Colitis Foundation of America (CCFA) come $1 million closer to finding a cure for Crohn’s disease ...More
January 31, 2008
Posted in News, Disorders
FDA Approves TYSABRI® for Moderate-to-Severe Crohn’s Disease

DUBLIN, Ireland & CAMBRIDGE, Mass.-- Elan Corporation, plc and Biogen Idec announced the approval of a supplemental Biologics License Application (sBLA) by the U.S. Food and Drug Administration (FDA) for TYSABRI® (natalizumab). TYSABRI is now approved for inducing and ...More
January 15, 2008
Posted in News, Disorders
Narrow Band Imaging Colonoscopy Identifies Flat Dysplastic Lesions in Ulcerative Colitis Patients

OAK BROOK, Ill. –– A pilot study from researchers at Kyushu University in Fukuoka, Japan, found that narrow band imaging (NBI) colonoscopy used in cancer surveillance for ulcerative colitis patients can identify flat dysplastic lesions. The research appears in the November ...More
November 20, 2007
Posted in News, Disorders, Procedures
Mesalamine Linked to Cancer Protection for High-Risk IBD Patients

PHILADELPHIA – Researchers found that mesalamine use among patients with inflammatory bowel disease (IBD) was associated with a decrease in incidence of colorectal cancer when comparing cases and controls. In the study presented at the 72nd Annual Scientific Meeting of the ...More
November 8, 2007
Posted in News, Disorders, Industry Issues, Procedures